Entropy Technologies LP Makes New $214,000 Investment in Maximus, Inc. (NYSE:MMS)

Entropy Technologies LP acquired a new position in shares of Maximus, Inc. (NYSE:MMS) in the third quarter, according to its most recent disclosure with the SEC. The firm acquired 2,295 shares of the health services provider’s stock, valued at approximately $214,000.

Other hedge funds also recently added to or reduced their stakes in the company. Assenagon Asset Management S.A. lifted its position in Maximus by 151.6% during the 2nd quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock worth $19,980,000 after acquiring an additional 140,481 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its position in Maximus by 942.9% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock worth $27,707,000 after acquiring an additional 292,300 shares during the period. Tidal Investments LLC lifted its position in Maximus by 238.9% during the 1st quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider’s stock worth $1,071,000 after acquiring an additional 8,997 shares during the period. SG Americas Securities LLC lifted its holdings in shares of Maximus by 609.6% in the 2nd quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock valued at $1,224,000 after buying an additional 12,266 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in shares of Maximus by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider’s stock valued at $520,922,000 after buying an additional 145,983 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Michelle F. Link sold 1,363 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at $607,841.52. This trade represents a 17.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.40% of the company’s stock.

Maximus Stock Down 2.3 %

MMS opened at $79.18 on Monday. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.59 and a quick ratio of 1.59. The business has a 50 day simple moving average of $89.02 and a 200-day simple moving average of $88.22. The stock has a market capitalization of $4.77 billion, a P/E ratio of 16.60 and a beta of 0.77. Maximus, Inc. has a 12 month low of $76.42 and a 12 month high of $93.97.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, November 30th. Stockholders of record on Friday, November 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.52%. Maximus’s dividend payout ratio is currently 25.16%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.